Home/Filings/4/0001127602-23-024071
4//SEC Filing

Lingamneni Anila 4

Accession 0001127602-23-024071

CIK 0000313143other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:20 PM ET

Size

4.6 KB

Accession

0001127602-23-024071

Insider Transaction Report

Form 4
Period: 2023-09-11
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
  • Sale

    Common Stock

    2023-09-11$90.00/sh2,305$207,45014,495 total
Footnotes (2)
  • [F1]Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
  • [F2]This number includes unvested restricted stock units previously reported.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001808414

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:20 PM ET
Size
4.6 KB